Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

GLUE – monte rosa therapeutics, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GLUE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/22
05:40 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Medium Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: Dimension Capital I, L.P.
Report
4/16
04:07 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
4/15
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Apr 14 Filed by: Warmuth Markus
Low Report
Form 4 Monte Rosa Therapeutics, For: Apr 14 Filed by: Warmuth Markus
Report
4/14
04:40 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Report
4/13
04:06 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Low Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
4/10
04:08 pm
glue
Form 4 Monte Rosa Therapeutics, For: Apr 09 Filed by: Nickson Philip
Low Report
Form 4 Monte Rosa Therapeutics, For: Apr 09 Filed by: Nickson Philip
Report
4/9
04:06 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Nickson Philip
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Nickson Philip
Report
4/8
04:08 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
4/7
04:10 pm
glue
Form 4 Monte Rosa Therapeutics, For: Apr 06 Filed by: Bowen Matthew
Neutral Report
Form 4 Monte Rosa Therapeutics, For: Apr 06 Filed by: Bowen Matthew
Report
4/7
04:05 pm
glue
Form 3 Monte Rosa Therapeutics, For: Apr 03 Filed by: Bowen Matthew
Neutral Report
Form 3 Monte Rosa Therapeutics, For: Apr 03 Filed by: Bowen Matthew
Report
3/19
04:05 pm
glue
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
Low Report
Form SCHEDULE 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
Report
3/18
11:38 am
glue
Form S-8 Monte Rosa Therapeutics,
Low Report
Form S-8 Monte Rosa Therapeutics,
Report
3/17
07:15 am
glue
Form 10-K Monte Rosa Therapeutics, For: Dec 31
Low Report
Form 10-K Monte Rosa Therapeutics, For: Dec 31
Report
3/17
07:04 am
glue
Form 8-K Monte Rosa Therapeutics, For: Mar 17
Low Report
Form 8-K Monte Rosa Therapeutics, For: Mar 17
Report
3/5
05:24 pm
glue
Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
Low Report
Form 4 Monte Rosa Therapeutics, For: Mar 04 Filed by: Dunn Edmund
Report
3/4
04:50 pm
glue
Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
Medium Report
Form 4 Monte Rosa Therapeutics, For: Mar 02 Filed by: Warmuth Markus
Report
3/4
04:45 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
3/2
05:03 pm
glue
Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
Low Report
Form 4 Monte Rosa Therapeutics, For: Feb 27 Filed by: Dunn Edmund
Report
3/2
04:25 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Low Report
Form 144 Monte Rosa Therapeutics, Filed by: Warmuth Markus
Report
3/2
04:16 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Low Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
2/27
04:29 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Dunn Edmund
Report
2/24
04:05 pm
glue
Form 4 Monte Rosa Therapeutics, For: Feb 23 Filed by: Janku Filip
Medium Report
Form 4 Monte Rosa Therapeutics, For: Feb 23 Filed by: Janku Filip
Report
2/23
05:42 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
Medium Report
Form 144 Monte Rosa Therapeutics, Filed by: Janku Filip
Report
2/17
04:15 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Low Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Report
2/17
04:12 pm
glue
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Low Report
Form SCHEDULE 13G/A Monte Rosa Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0